Unlocked Access
Pyoderma Gangrenosum Following Total Colectomy for Ulcerative Colitis
December 2025 | Volume 24 | Issue 12 | Case Reports | 9363 | Copyright © December 2025
INDIVIDUAL ARTICLE: The Dark Side of Oral Antibiotics: Adverse Events of Consideration in Dermatology
November 2025 | Volume 24 | Issue 11 | Supplement Individual Articles | s4 | Copyright © November 2025
Antibiotics remain a cornerstone in the management of dermatologic conditions such as acne and hidradenitis suppurativa, underscoring the need for responsible antibiotic stewardship. This article...
Read MoreINDIVIDUAL ARTICLE: Vehicle Matters: Triple Combo for Acne Vulgaris
November 2025 | Volume 24 | Issue 11 | Supplement Individual Articles | s1 | Copyright © November 2025
Although data suggest that antibiotic use by dermatologists is decreasing, our specialty still has the highest rates of oral antibiotic prescribing across all fields of medicine......
Read MoreNECASA II: A Practical Algorithm Integrating Skincare in the Management of Adult Female Acne in the Nordic European Countries
November 2025 | Volume 24 | Issue 11 | Original Article | 1094 | Copyright © November 2025
Background: Adult female acne presents challenges, including increased prevalence, distinct clinical manifestations, heightened skin sensitivity, treatment-related intolerance, a...
Read MoreMolecular Insights: Immune and Barrier Dysregulation in Seborrheic Dermatitis
November 2025 | Volume 24 | Issue 11 | Features | 1144 | Copyright © November 2025
INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema
October 2025 | Volume 24 | Issue 10 | Supplement Individual Articles | 025412 | Copyright © October 2025
Chronic hand eczema (CHE) affects up to 10% of the general population and is associated with significant physical discomfort, impaired hand function, and reduced quality of life, yet effective lo...
Read MoreINDIVIDUAL ARTICLE: VEHICLES MATTER
October 2025 | Volume 24 | Issue 10 | Supplement Individual Articles | 025411 | Copyright © October 2025
Management of CHE can be complicated by numerous factors, including the possibility that contact irritants or allergens–including occupational exposures–contribute to the condition. Additi...
Read MoreFULL SUPPLEMENT: Time To Get Hands On: Delgocitinib's Promise For Chronic Hand Eczema
October 2025 | Volume 24 | Issue 10 | Department | 025410 | Copyright © October 2025
Despite its prevalence and impact on patients’ lives, treatment options are limited, with many patients showing inadequate response or intolerance to topical corticosteroids and systemic immunos...
Read MoreSAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare
October 2025 | Volume 24 | Issue 10 | Original Article | 1012 | Copyright © October 2025
Background: Atopic dermatitis (AD) is a common heterogeneous disorder that typically starts in infancy and early childhood, is associated with the development of comorbidities, a...
Read MoreThe Emerging Role of Oncodermatology in a Hemato-Oncology Unit in a Tertiary Hospital
October 2025 | Volume 24 | Issue 10 | Original Article | 1018 | Copyright © October 2025
Background: Our dermatology department consistently receives the largest proportion of internal on-call referrals from the Hematology-Oncology Department. Individuals with hemato...
Read MoreExamining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin
October 2025 | Volume 24 | Issue 10 | Features | 1046 | Copyright © October 2025
Skin rejuvenation treatments, including chemical peels and biostimulatory therapies, aim to improve facial aging concerns. However, these treatments have limitations, including efficacy, safety, ...
Read MoreThe Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Case Reports | 1043 | Copyright © October 2025
Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report
October 2025 | Volume 24 | Issue 10 | Case Reports | 1041 | Copyright © October 2025
The Dermatologic Hazards of Nail Product Usage
October 2025 | Volume 24 | Issue 10 | Features | 1051 | Copyright © October 2025
The major dermatologic adverse effect of nail polish that has been reported is an allergic contact dermatitis. This can within the ungual and periungual region, but it can also be diffuse and spr...
Read MoreTrichoscopic Images Observed in Popular Head Spa Salons: Are We Headed in the Right Direction?
September 2025 | Volume 24 | Issue 9 | Features | 942 | Copyright © September 2025
Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management
September 2025 | Volume 24 | Issue 9 | Case Reports | 938 | Copyright © September 2025
Background: Alopecia universalis (AU) is the most severe form of alopecia areata (AA), characterized by complete scalp and body hair loss. While post-COVID-19 hair loss is often ...
Read MoreIndirect Tightening of Lower Eyelid Skin Following Poly-L-lactic Acid Treatment of the Cheeks
September 2025 | Volume 24 | Issue 9 | Features | 946 | Copyright © September 2025
Dermatological Safety of Cosmetic Products Marketed to Children: Insights on the Sephora Kids Phenomenon
September 2025 | Volume 24 | Issue 9 | Features | 949 | Copyright © September 2025
The "Sephora Kids" trend, where children, especially tweens and teens, are increasingly using makeup and skincare products marketed by beauty retailers, presents notable dermatological challenges...
Read MoreThe Impact of an AGE-Inhibiting Moisturizer on Procedure Effectiveness
September 2025 | Volume 24 | Issue 9 | Original Article | 904 | Copyright © September 2025
The accumulation of endogenous advanced glycation end products (AGEs) has been shown to degrade the integrity of the extracellular matrix in the dermis, resulting in signs of aging. Resurfac...
Read MoreThe Atopic Dermatitis Continuum: An Updated Paradigm for a Common Disorder and a Novel Multipurpose Treatment Option
September 2025 | Volume 24 | Issue 9 | Original Article | 920 | Copyright © September 2025
Background: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disorder characterized by complex interactions among Staphylococcus aureus colonization and ...
Read More© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
